Twelve patients with PVC's were studied to assess the possible role of the vagus nerves in suppressing PVC's. All were without significant heart disease and under forty years of age. A series of five autonomically active drugs, including vagotonic and vagolytic agents, was administered intravenously, each drug being given after the effects of the previous one had abated. Two of the patients did not have PVC's at the time of study. Of the remaining ten patients, five showed vagally mediated suppression of PVC's. Phenylephrine (40 to 60 mug per minute) reduced HR, from an average of 63.2 bpm to 48.5 bpm by a vagally mediated reflex, and decreased PVC incidence in all five patients. The per cent of ventricular heart beats which were PVC's (per cent PVC) decreased from an average of 18.2 per cent to 3.2 per cent in these patients (p smaller than 0.005 in each case). Edrophonium (10 mg.) produced less bradycardia and less reliable PVC suppression. In two of these five patients, atropine (1.5 mg.) increased PVC incidence markedly, although the per cent PVC did not change significantly because of the concomitant tachycardia. These data suggest that strongly increased vagal tone can suppress PVC's in a significant percentage of such pa...Continue Reading
Prognostic importance of premature beats following myocardial infarction. Experience in the coronary drug project
Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study
Effects of acetylcholine on automaticity and conduction in the proximal portion of the His-Purkinje specialized conduction system of the dog
Histochemical and chemical studies of the localization of adrenergic and cholinergic nerves in normal and denervated cat hearts
A depressant effect of acetylcholine on the idio-ventricular pacemaker of the isolated perfused rabbit heart
The influence of cardiac cholinergic activation on the induction and maintenance of ventricular fibrillation
Effect of phenylephrine on focal atrial fibrillation originating in the pulmonary veins and superior vena cava
Holter-guided identification of premature ventricular contractions susceptible to suppression by beta-blockers
Effect of vagus nerve stimulation upon excitability of the canine ventricle. Role of sympathetic-parasympathetic interactions
Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog
Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole (RE) threshold
Reentrant ventricular arrhythmias in the late myocardial infarction period. 6. Effect of the autonomic system
Role of higher nervous activity in ventricular arrhythmia and sudden cardiac death: implications for alternative antiarrhythmic therapy
The vulnerability of the right atrium. II. Correlations between vulnerability and the atrial refractory periods (author's transl)
Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.
Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.
Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.